Literature DB >> 22817756

Long non-coding RNAs and human disease.

Lorna W Harries1.   

Abstract

The central dogma of molecular biology states that DNA is transcribed into RNA, which in turn is translated into proteins. We now know, however, that as much as 50% of the transcriptome has no protein-coding potential, but rather represents an important class of regulatory molecules responsible for the fine-tuning of gene expression. Although the role of small regulatory RNAs [microRNAs and siRNAs (small interfering RNA)] is well defined, another much less characterized category of non-coding transcripts exists, namely lncRNAs (long non-coding RNAs). Pervasively expressed by eukaryotic genomes, lncRNAs can be kilobases long and regulate their targets by influencing the epigenetic control, chromatin status, mRNA processing or translation capacity of their targets. In the present review, I outline the potential mechanisms of action of lncRNAs, the cellular processes that have been associated with them, and also explore some of the emerging evidence for their involvement in common human disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22817756     DOI: 10.1042/BST20120020

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  122 in total

Review 1.  Long noncoding RNA and its contribution to autism spectrum disorders.

Authors:  Jie Tang; Yizhen Yu; Wei Yang
Journal:  CNS Neurosci Ther       Date:  2017-06-20       Impact factor: 5.243

Review 2.  All's well that transcribes well: non-coding RNAs and post-stroke brain damage.

Authors:  Raghu Vemuganti
Journal:  Neurochem Int       Date:  2013-08-15       Impact factor: 3.921

3.  RNA element discovery from germ cell to blastocyst.

Authors:  Molly S Estill; Russ Hauser; Stephen A Krawetz
Journal:  Nucleic Acids Res       Date:  2019-03-18       Impact factor: 16.971

4.  Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma.

Authors:  Xiao-Hui Sun; Li-Bin Yang; Xiao-Lin Geng; Ran Wang; Zhi-Chang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 5.  Focusing on long noncoding RNA dysregulation in gastric cancer.

Authors:  Lu Gan; Midie Xu; Yi Zhang; Xia Zhang; Weijian Guo
Journal:  Tumour Biol       Date:  2014-12-13

Review 6.  From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport.

Authors:  Alberto Dávalos; Carlos Fernández-Hernando
Journal:  Pharmacol Res       Date:  2013-02-19       Impact factor: 7.658

Review 7.  Transcriptional regulation and its misregulation in disease.

Authors:  Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

8.  Long noncoding RNA UCA1 promotes the proliferation of hypoxic human pulmonary artery smooth muscle cells.

Authors:  Tian-Tian Zhu; Rui-Li Sun; Ya-Ling Yin; Jin-Ping Quan; Ping Song; Jian Xu; Ming-Xiang Zhang; Peng Li
Journal:  Pflugers Arch       Date:  2018-10-23       Impact factor: 3.657

9.  Expression of long non-coding RNA ZEB1-AS1 in esophageal squamous cell carcinoma and its correlation with tumor progression and patient survival.

Authors:  Yong-Lian Wang; Yu Bai; Wen-Jian Yao; Ling Guo; Zhong-Min Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 10.  Long noncoding RNAs in psychiatric disorders.

Authors:  Lingjun Zuo; Yunlong Tan; Zhiren Wang; Ke-Sheng Wang; Xiangyang Zhang; Xiangning Chen; Chiang-Shan R Li; Tong Wang; Xingguang Luo
Journal:  Psychiatr Genet       Date:  2016-06       Impact factor: 2.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.